[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 1543, "companyOfficers": [{"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 55, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 5, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1714521600, "maxAge": 86400, "priceHint": 4, "previousClose": 4.71, "open": 4.8031, "dayLow": 4.6895, "dayHigh": 4.94, "regularMarketPreviousClose": 4.71, "regularMarketOpen": 4.8031, "regularMarketDayLow": 4.6895, "regularMarketDayHigh": 4.94, "beta": 1.602, "forwardPE": -123.25, "volume": 4598069, "regularMarketVolume": 4598069, "averageVolume": 6976245, "averageVolume10days": 3554440, "averageDailyVolume10Day": 3554440, "bid": 4.89, "ask": 4.93, "bidSize": 300, "askSize": 1400, "marketCap": 692186816, "fiftyTwoWeekLow": 3.53, "fiftyTwoWeekHigh": 11.36, "priceToSalesTrailing12Months": 0.7036528, "fiftyDayAverage": 4.7186, "twoHundredDayAverage": 5.9149, "currency": "USD", "enterpriseValue": 402099008, "profitMargins": -0.55409, "floatShares": 123637406, "sharesOutstanding": 140403008, "sharesShort": 43769652, "sharesShortPriorMonth": 48126414, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.3127, "heldPercentInsiders": 0.049850002, "heldPercentInstitutions": 0.57257, "shortRatio": 10.22, "shortPercentOfFloat": 0.36450002, "bookValue": -5.139, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -545062016, "trailingEps": -5.41, "forwardEps": -0.04, "pegRatio": 0.09, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.409, "enterpriseToEbitda": -0.787, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "NVAX", "underlyingSymbol": "NVAX", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "firstTradeDateEpochUtc": 818173800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "cdb3cddb-5091-3918-86d6-9b4894e61c6c", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.93, "targetHighPrice": 38.0, "targetLowPrice": 4.0, "targetMeanPrice": 15.4, "targetMedianPrice": 11.0, "recommendationMean": 2.7, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 568505024, "totalCashPerShare": 4.062, "ebitda": -510985984, "totalDebt": 280635008, "quickRatio": 0.529, "currentRatio": 0.7, "totalRevenue": 983705024, "revenuePerShare": 9.762, "returnOnAssets": -0.17018, "freeCashflow": -979221888, "operatingCashflow": -713966976, "revenueGrowth": -0.185, "grossMargins": -0.09633, "ebitdaMargins": -0.51945, "operatingMargins": -0.63008, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-04"}]